References

Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2024 · External reference

Periodic Oxaliplatin Administration in Synergy With PER2‐Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC

10.1002/advs.201900667 · 2019 · External reference

Deciphering Drug Resistance in Gastric Cancer: Potential Mechanisms and Future Perspectives

10.1016/j.biopha.2024.116310 · 2024 · External reference

METTL3 Promotes Drug Resistance to Oxaliplatin in Gastric Cancer Cells Through DNA Repair Pathway

10.3389/fphar.2023.1257410 · 2023 · External reference

A Metabolomic Approach to Identifying Platinum Resistance in Ovarian Cancer

10.1186/s13048-015-0140-8 · 2015 · External reference

‘Metabolic Reprogramming’ in Ovarian Cancer Cells Resistant to Cisplatin

10.2174/156800911794328501 · 2011 · External reference

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells

10.1038/s41598-017-09206-0 · 2017 · External reference

MACC1 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin by Regulating FASN Expression

10.3892/or.2017.5519 · 2017 · External reference

Lysophosphatidylcholine Acyltransferase 2‐Mediated Lipid Droplet Production Supports Colorectal Cancer Chemoresistance

10.1038/s41467-017-02732-5 · 2018 · External reference

Methylmalonic Acidemia. A Disorder Associated With Acidosis, Hyperglycinemia, and Hyperlactatemia

10.1111/j.1651-2227.1968.tb07314.x · 1968 · External reference

Recognition, Isolation, and Characterization of Rat Liver D‐Methylmalonyl Coenzyme A Hydrolase

10.1016/s0021-9258(17)44433-4 · 1983 · External reference

The Complex Machinery of Human Cobalamin Metabolism

10.1002/jimd.12593 · 2023 · External reference

Age‐Induced Accumulation of Methylmalonic Acid Promotes Tumour Progression

10.1038/s41586-020-2630-0 · 2020 · External reference

Population Reference Values for Serum Methylmalonic Acid Concentrations and Its Relationship With Age, Sex, Race‐Ethnicity, Supplement Use, Kidney Function and Serum Vitamin B12 in the Post‐Folic Acid Fortification Period

10.3390/nu10010074 · 2018 · External reference

Elevated Serum Methylmalonic Acid Concentrations Are Common Among Elderly Americans

10.1093/jn/132.9.2799 · 2002 · External reference

Methylmalonic Acid in Aging and Disease

10.1016/j.tem.2023.11.001 · 2024 · External reference

Serum Methylmalonic Acid Concentrations at Breast Cancer Diagnosis Significantly Correlate With Clinical Frailty

10.1007/s11357-023-00908-0 · 2024 · External reference

Methylmalonic Acid Induces Metabolic Abnormalities and Exhaustion in CD8(+) T Cells to Suppress Anti‐Tumor Immunity

10.1038/s41388-024-03191-1 · 2025 · External reference

Tumor‐Produced and Aging‐Associated Oncometabolite Methylmalonic Acid Promotes Cancer‐Associated Fibroblast Activation to Drive Metastatic Progression

10.1038/s41467-022-33862-0 · 2022 · External reference

Sophoridine Inhibits Proliferation and Migration by Targeting PIM1 in Breast Cancer

10.1080/13880209.2025.2537123 · 2025 · External reference

The Emerging Role of Dysregulated Propionate Metabolism and Methylmalonic Acid in Metabolic Disease, Aging, and Cancer

10.1016/j.cmet.2025.01.005 · 2025 · External reference

GammaH2AX and Cancer

10.1038/nrc2523 · 2008 · External reference

ATAD5 Promotes Replication Restart by Regulating RAD51 and PCNA in Response to Replication Stress

10.1038/s41467-019-13667-4 · 2019 · External reference

Methylmalonic Acidemia Controlled With Oral Administration of Vitamin B12

1976 · External reference

Plasma L‐Aspartic Acid Predicts the Risk of Gastric Cancer and Modifies the Primary Prevention Effect: A Multistage Metabolomic Profiling and Mendelian Randomization Study

2025 · External reference

Gut Microbial Metabolite 4‐Hydroxybenzeneacetic Acid Drives Colorectal Cancer Progression via Accumulation of Immunosuppressive PMN‐MDSCs

10.1172/jci199353 · 2025 · External reference

NBS1 Lactylation Is Required for Efficient DNA Repair and Chemotherapy Resistance

10.1038/s41586-024-07620-9 · 2024 · External reference

Glutamine Metabolism Controls Amphiregulin‐Facilitated Chemoresistance to Cisplatin in Human Chondrosarcoma

10.7150/ijbs.86116 · 2023 · External reference

N(6)‐Methyladenosine‐Mediated LDHA Induction Potentiates Chemoresistance of Colorectal Cancer Cells Through Metabolic Reprogramming

10.7150/thno.73746 · 2022 · External reference

Serum Vitamin Levels and Their Relationships With Other Biomarkers in Korean Breast Cancer Patients

10.3390/nu12092831 · 2020 · External reference

Altered Propionate Metabolism Contributes to Tumour Progression and Aggressiveness

10.1038/s42255-022-00553-5 · 2022 · External reference

Methylmalonic Acid at the Serum Level in the Elderly Contributes to Cell Growth via Mitochondrial Dysfunction in Colorectal Cancer Cell Spheroids

10.1016/j.bbrep.2024.101909 · 2025 · External reference

Methylmalonic Acid Promotes Colorectal Cancer Progression via Activation of Wnt/β‐Catenin Pathway Mediated Epithelial‐Mesenchymal Transition

10.1186/s12935-023-02973-z · 2023 · External reference

Concordant and Opposite Roles of DNA‐PK and the ‘Facilitator of Chromatin Transcription’ (FACT) in DNA Repair, Apoptosis and Necrosis After Cisplatin

10.1186/1476-4598-10-74 · 2011 · External reference

The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double‐Strand Break Repair

10.1016/j.molcel.2018.02.002 · 2018 · External reference

DNA Strand Breaks and Apoptosis Induced by Oxaliplatin in Cancer Cells

10.1016/s0006-2952(03)00260-0 · 2003 · External reference

L3MBTL2 Regulates Chromatin Remodeling During Spermatogenesis

10.1038/s41418-019-0283-z · 2019 · External reference

HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1‐Inhibitor in Serous Ovarian Cancer

10.7150/ijbs.65589 · 2022 · External reference

Kinome Screen of Ferroptosis Reveals a Novel Role of ATM in Regulating Iron Metabolism

10.1038/s41418-019-0393-7 · 2020 · External reference

Participation of the ATR/CHK1 Pathway in Replicative Stress Targeted Therapy of High‐Grade Ovarian Cancer

10.1186/s13045-020-00874-6 · 2020 · External reference

Extracellular Signal‐Regulated Kinases Modulate DNA Damage Response—A Contributing Factor to Using MEK Inhibitors in Cancer Therapy

10.2174/092986711798194388 · 2011 · External reference

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

10.1158/2159-8290.cd-14-0849 · 2015 · External reference

The Cell Cycle Checkpoint Inhibitors in the Treatment of Leukemias

10.1186/s13045-017-0443-x · 2017 · External reference

ATAD5 Deficiency Alters DNA Damage Metabolism and Sensitizes Cells to PARP Inhibition

10.1093/nar/gkaa255 · 2020 · External reference

ATAD5‐BAZ1B Interaction Modulates PCNA Ubiquitination During DNA Repair

10.1038/s41467-024-55005-3 · 2024 · External reference

Serum Vitamin B12 and Folate Status Among Patients With Chemotherapy Treatment for Advanced Colorectal Cancer

10.1080/03009730903027172 · 2009 · External reference

Prevalence and Aetiology of Anaemia in Lymphoid Malignancies

2013 · External reference

Antitumor Activity of Sitagliptin and Vitamin B12 on Ehrlich Ascites Carcinoma Solid Tumor in Mice

10.1002/jbt.22645 · 2021 · External reference